More than ever, pharma firms are under increasing pressure to harness the power of AI, advanced analytics, and machine ...

Amazon Web Services (AWS) has committed $100 million in AI and cloud technology capacity to support the building of health ...

The takeover deal – worth up to $1.15 billion including $550 million in upfront cash – will upgrade the Dutch biotech's ...

GSK has claimed its second breakthrough designation from the FDA for antibody-drug conjugate GSK5764227, which it licensed from China's Hansoh Pharma in a $1.7 billion deal. The status has been given ...

The comprehensive failure of Lp (a)HORIZON has cast a pall over the prospects for other Lp (a)-targeting drugs, including ...

Patients with muscle-invasive bladder cancer can now receive NHS treatment with a regimen of MSD's Keytruda and Astellas' ...

Boehringer Ingelheim is paying $358 million upfront to claim options on up to six antibody-drug conjugates (ADCs) and T cell ...

Belén Garijo, who took over the reins of the French pharma group in April, said this morning that Sanofi's "whole ...

Eli Lilly has signed an agreement with Hims & Hers that will see its weight-loss therapies Zepbound and Foundayo sold ...

While praising the breadth of its pipeline, AstraZeneca has launched a three-year cost-cutting programme that will aim to ...

Theramex, a London, UK-based specialty pharma company focusing on women's health, is changing hands in a deal reportedly ...

Bayer's pharma unit has reached a "turning point" in its growth trajectory as sales of new medicines rose 6.4% in the third ...